[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Healthcare Market Research Reports & Industry Analysis

Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.

Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.

The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.

Publications found: 113,367
Sort by:

GLAXOSMITHKLINE - Novel Combo therapy (BRAF+MEK) filed in Europe – Potential New SoC for BRAF positive metastatic melanoma patients

US$ 90.00

... MEK inhibitor) as monotherapy and in combination with dabrafenib (BRAF inhibitor) as combo therapy for the treatment of metastatic melanoma with a BRAF V600 mutation ... days. The accelerated assessment and early filing of the combination therapy is based on extraordinary efficacy shown in PhII study which doubled ...

February 2013 3 pages

NOVO NORDISK , SANOFI - Tresiba and Ryzodeg delayed in the US: Lantus protected – Reduce PT to DKK 950

US$ 90.00

Post complete response letter issued by the USFDA to NOVOB for Tresiba and Ryzodeg, we reduce our PT for NOVOB from DKK 1000 to DKK 950. Considering the US constitutes the biggest long acting insulin market (Lantus-US sales: $4b; Western EU: $1.0b; RoW: $400m; Emerg mkt: $1.0b), the CRL has clouded the ...

February 2013 2 pages

Competitor Analysis: FSH, hCG and LH - Therapeutic Proteins for Assisted Reproductive Technology (ART)

US$ 335.00

... (ART) as of February 2013 provides a competitor analysis in the development pipeline of novel recombinant and purified FSH, hCG and LH receptor agonists for ... , the report lists company-specific R&D pipelines of FSH, LH and hCG products and projects. Competitor projects are listed in a tabular format providing ...

February 2013 43 pages

Global and China Hemodialysis Industry Report, 2012-2013

US$ 2,200.00

... Science and Technology, etc. Given the huge potential in Chinese hemodialysis market, several listed companies have tapped into the field, ... landscape, import & export and development prediction of Chinese hemodialysis industry; Global and China hemodialysis equipment market segments and competition pattern ...

January 2013 91 pages

Brazilian Market for Wound and Tissue Management

US$ 6,995.00

... 2012, the total Brazilian market for wound and tissue management was valued at nearly $632 million. The Brazilian wound and tissue ... growth. Scope: This report pertains to a forecast period of 10 years (2008 – 2018) for Brazil. Report Contents: Competitor Analysis Identified Strategic Opportunities ...

January 2013 262 pages

European Wound and Tissue Management Markets

US$ 10,995.00

... wounds including surgical incisions, burns, and ulcers. The European wound and tissue management market is expected to be driven by an aging population and rising ... closure segments of the market. Technological developments such as negative pressure wound therapy and skin substitutes are also driving the market ...

January 2013 458 pages

Global Prefilled Syringes Market: Trends & Opportunities (2012-2017)

US$ 800.00

... filled syringes a fast-growing alternative to vials for many parenteral drugs such as vaccines, anticoagulants and therapeutic proteins. The report titled “Global Prefilled Syringes Market: Trends & Opportunities (2012-2017)” provides an in-depth analysis of the global prefilled syringes market with major focus on biggest healthcare markets of U.S and Europe. It also ...

January 2013 78 pages

The Path to Product Inclusion in Clinical Guidelines: Strategies for Success

US$ 495.00

... Pharma do to maximise the credibility and visibility of its products? Overview The Path to Product Inclusion in Clinical Guidelines: Strategies for Success If you ... defining the clinical need around which you need to design your future products.” Charlie Buckwell, chief executive, McCann Complete Medical

January 2013 49 pages

Cellular Therapy and Cord Blood 2013 Market Report

US$ 2,119.00

... is the most up-to-date market report focusing on Cellular Therapy and the HSCT/Cord Blood Market Landscape, published by Select Biosciences. In this ... . Select Biosciences has also provided a detailed quantitative analysis of the cord blood field as it is rapidly evolving. Our coverage provides hard numbers ...

January 2013 172 pages

New Horizons in Healthcare Case Management: Benchmarks, Metrics and Models

US$ 299.00

... more than 90 figures and tables and answers more than 50 questions on patient-centered case management. Download the executive summary and complete table of contents for New Horizons in Healthcare Case Management: Benchmarks, Metrics and Models. Market research by the Healthcare ...

January 2013 200 pages

Personalized Medicine Market Opportunities

US$ 229.00

... and scientists are looking at options for curing AIDS as well with personalized medicines. Often described as the right treatment for the right ... technology platforms as well as the technological requirements for the personalized medicines market. Challenges facing the industry as well as a look at the key ...

January 2013 178 pages

CELGENE - Prospects Bright beyond Revlimid in MM - New Products + Label Expansion

US$ 140.00

With our conservative view on Revlimid – opportunity in EU (no approval in NDMM and Maintenance setting), reimbursement in China, and patent challenges; we expect net product sales’ CAGR (2013-17) of 17% (vs. CELG’s guidance: 19%) including risk adjusted late stage pipeline. We are positive on upcoming ...

January 2013 6 pages

ROCHE, Confidence building up on next gen. Rituxan (GA101)

US$ 90.00

Roche seems to be on track of delivering sustainable growth as it announced ... forward. With Perjeta and T-DM1 as well shaping up well, Roche is on a strong ground to sustain its revenues from Herceptin ... expected to reach the market in 2016, but by then, Roche would have GA101 on the market which would fend off ...

January 2013 3 pages

DISHMAN, Worry on Cash Flow Continues

US$ 140.00

... visibility of free cash flow generation, we continue to remain concerned about the fate of highly levered (operating and financial) business model of Dishman. The fact ... land clearly signifies that company is not generating sufficient free cash flow to service its debt. As the proposed sale of SEZ land has ...

January 2013 6 pages

Drivers of M&A in 2013-2016: PI3Ks and BTK Inhibitors

US$ 2,000.00

... (CELG) M&A in Kinase Inhibitors in the last 5 years Related Milestones/catalysts in 2013-14 Combination Studies – PI3K, BTK inhibitors with Rituxan, Bendamustine in hematological ...

January 2013 62 pages

GILEAD SCIENCES - New HIV + HCV Products to Sustain the Growth Trajectory

US$ 140.00

nitial sales of newly added HIV products – Complera/ Eviplera (L, truvada + rilpivirine), Stribild (L in US, ... products contributed to the impressive 4Q12/FY13 results of Gilead. Positive data of Sofosbuvir (PMI, PhIII) in ... Through life cycle management of products for HIV, late stage HCV drugs and focus on ...

January 2013 8 pages

PHARMACYCLICS - Ibrutinib - Promising to Deliver More

US$ 140.00

... that there is meaningful upside on positive PhIII data and approval of Ibrutinib (PCI-32765, PhIII, BTK inhibitor, partnered with JNJ, PhIII ... of time, and iv) Patient tolerability including lack of bone marrow damage. Ibrutinib is a best-in-class among leukemia drugs, showed durable efficacy in Tx-naïve (TN) ...

January 2013 14 pages

Real Time Location Systems (RTLS) Market in Healthcare Industry 2011 - 2015

US$ 900.00

... on RTLS comprises: Quantification and analysis of the global RTLS market in the healthcare industry Current market size and forecast of the RTLS in the healthcare industry Illustration of drivers and trends Key factors affecting RTLS market in the healthcare industry Competitive Landscape: Profiles of ...

January 2013 20 pages

Worldwide Facial Rejuvenation Markets, 4th Edition

US$ 3,995.00

... on extensive interviews with senior management of top companies in the worldwide facial rejuvenation market. As part of its coverage, the 4th Edition includes ... pressures in the new millennium. While plastic surgery and cosmetic rejuvenation modalities offered this opportunity, it also came with a price and ...

January 2013 248 pages

SYMBIO - Significant Upside still Remains: Bendamustine + Regosertib + Cash to In-license More!

US$ 90.00

... gone up by ~185% since our initiation on September 14th 2012. SymBio’s focus on Japan and select Asia Pacific Rim countries market along with ... details, please read our report released on 16th January. 2013 on SymBio titled “Significant Upside still Remains: Bendamustine + Regosertib + Cash to In-license More!”

January 2013 5 pages

Epigenetic Therapies and Technologies: World Market Prospects 2013-2023

US$ 2,400.00

... Our work explains, exploring many issues. What affects the application of epigenetics? Our report discusses issues and events affecting that science, ... and commercial possibilities. Nine ways Epigenetic Therapies and Technologies: World Market Prospects 2013-2023 helps you To sum up, our investigation ...

January 2013 195 pages

Competitor Analysis: Enzyme Replacement Therapies

US$ 403.00

... Intelligence Report Enzyme Replacement & Enhancement Therapies (ERT) as of January 2013 provides a competitor analysis in the development pipeline of novel enzyme replacement therapies and of enzyme enhancement therapies to treat human genetic diseases/lysosomal storage diseases and exocrine pancreatic ...

January 2013 74 pages

The US Eyecare Industry Outlook to 2017 - Lenses Segment Continues to Maintain its Dominance

US$ 720.00

Executive summary The report titled “The US Eyecare Industry Outlook to 2017 – Lenses Segment Continues to Maintain its Dominance” provides a comprehensive analysis ... adults were reported to be wearing OTC readers along with close to ~million unit sales. The US ophthalmic lenses market was led by the French ...

December 2012 100 pages

Closing the Loop: delivering real-world commercial benefit from closed-loop marketing

US$ 595.00

Your step-by-step guide to adapting to real time change. Over the past decade, closed loop marketing (CLM) has been a buzzword in pharma marketing ... actionable by themselves. This is where most companies are stuck in the closed-loop marketing cycle.” Marc Valdiviezo, former director of multichannel marketing, Pfizer.

December 2012 59 pages

Digital Health Quarterly 1Q 2013 2Q 2013

US$ 1,500.00

The Market Tracker: Digital Health Quarterly offers in-depth analysis of the latest corporate news, industry events, passed and pending legislation, and government directives related to the digital health industry.

December 2012 17 pages

Digital Health Quarterly 2Q 2013 3Q 2013

US$ 1,500.00

The Market Tracker: Digital Health Quarterly offers in-depth analysis of the latest corporate news, industry events, passed and pending legislation, and government directives related to the digital health industry.

December 2012 17 pages

Digital Health Quarterly 3Q 2013 4Q 2013

US$ 1,500.00

The Market Tracker: Digital Health Quarterly offers in-depth analysis of the latest corporate news, industry events, passed and pending legislation, and government directives related to the digital health industry.

December 2012 17 pages

Digital Health Quarterly 4Q 2012 1Q 2013

US$ 1,500.00

The Market Tracker: Digital Health Quarterly offers in-depth analysis of the latest corporate news, industry events, passed and pending legislation, and government directives related to the digital health industry.

December 2012 19 pages

Global Healthcare Packaging Market 2013-2023

US$ 2,401.00

... methodology allows insight into the key drivers and restraints behind market dynamics and competitive developments, as well as identifying the technological issues. ... prospects for established companies and new market entrants. How the Global Healthcare Packaging Market 2013-2023 report can benefit you ...

December 2012 175 pages

Research Report on China's High-end Medical Treatment Industry, 2013-2017

US$ 2,800.00

... are on the rather low level. The rich and foreigners in China attach importance to quality and privacy of medical services and they are ... is easier to create characteristics through equipment, technologies and services, China's high-end medical services are concentrated in these fields. However, investments in ...

December 2012 50 pages

France Flow Cytometry Market: Innovative Technologies and Emerging Business Opportunities

US$ 2,880.00

... report contains 146 pages, 15 tables and presents a comprehensive analysis of the French flow cytometry market, including: Major issues pertaining to the French ... . Five-year reagent and instrument sales forecasts. Sales and market shares of leading reagent and instrument suppliers. Review of current and ...

December 2012 146 pages

Germany Flow Cytometry Market: Innovative Technologies and Emerging Business Opportunities

US$ 2,880.00

This report contains 147pages, 15 tables and presents a comprehensive analysis of the German flow cytometry market, including: Major issues pertaining to the German ... . Five-year reagent and instrument sales forecasts. Sales and market shares of leading reagent and instrument suppliers. Review of current and ...

December 2012 147 pages

Italy Flow Cytometry Market: Innovative Technologies and Emerging Business Opportunities

US$ 2,880.00

... report contains 142 pages, 15 tables and presents a comprehensive analysis of the Italian flow cytometry market, including: Major issues pertaining to the Italian ... . Five-year reagent and instrument sales forecasts. Sales and market shares of leading reagent and instrument suppliers. Review of current and ...

December 2012 142 pages

Japan Flow Cytometry Market: Innovative Technologies and Emerging Business Opportunities

US$ 3,600.00

... report contain 142 pages, 15 tables and presents a comprehensive analysis of the Japanese flow cytometry market, including: Major issues pertaining to the Japanese ... . Five-year reagent and instrument sales forecasts. Sales and market shares of leading reagent and instrument suppliers. Review of current and ...

December 2012 142 pages

Spain Flow Cytometry Market: Innovative Technologies and Emerging Business Opportunities

US$ 2,880.00

... report contains 140 pages, 15 tables and presents a comprehensive analysis of the Spanish flow cytometry market, including: Major issues pertaining to the Spanish ... . Five-year reagent and instrument sales forecasts. Sales and market shares of leading reagent and instrument suppliers. Review of current and ...

December 2012 140 pages

UK Flow Cytometry Market: Innovative Technologies and Emerging Business Opportunities

US$ 2,880.00

This report contains 146 pages, 15 tables and presents a comprehensive analysis of the UK flow cytometry market, including: Major issues pertaining to the ... systems. Five-year reagent and instrument sales forecasts. Sales and market shares of leading reagent and instrument suppliers. Review of current and ...

December 2012 146 pages

US Flow Cytometry Market: Innovative Technologies and Emerging Business Opportunities

US$ 4,720.00

This report contains 147 pages, 17 tables and presents a comprehensive analysis of the US flow cytometry market, including: Major issues pertaining to the ... systems. Five-year reagent and instrument sales forecasts. Sales and market shares of leading reagent and instrument suppliers. Review of current and ...

December 2012 147 pages

European Flow Cytometry Market: Innovative Technologies and Emerging Business Opportunities

US$ 10,000.00

... placements and installed base by manufacturer and model, as well as sales and market shares of leading instrument and reagents suppliers. This 5-country report will ... in the flow cytometry markets during the next five years. The report explores future marketing and technological trends in five major European ...

December 2012 270 pages

Tele-Health Carts, Servers, and Monitoring: Market Shares, Strategies, and Forecasts, Worldwide, 2012 to 2018

US$ 3,700.00

WinterGreen Research announces that it has a new study on Tele-Health Carts, Servers, and Monitoring Market Shares and Forecasts, Worldwide, 2012 ... anticipated to grow rapidly worldwide as efficiencies of scale are realized for monitoring and treating people with chronic conditions in a more standardized manner ...

December 2012 366 pages

Diagnostic Testing in Ancillary Hospital Locations: Innovative Technologies and Emerging Business Opportunities

US$ 10,000.00

... and physicians, and changing consumer demands are shifting diagnostic testing from hospitals closer to the patient. Market Segmentation Analysis Review of ... during the next ten years. Design criteria for POC testing products. Alternative business expansion strategies. Potential market entry barriers ...

December 2012 973 pages

Point-of-Care Testing Markets: Innovative Technologies and Emerging Business Opportunities

US$ 10,000.00

... and selling prices. Technology Review Emerging technologies and their applications for POC testing. Comprehensive listings of companies developing or marketing POC diagnostic technologies and products, by test. Competitive Assessments Assessments of major suppliers and emerging market entrants, ...

December 2012 1007 pages

Competitor Analysis: Toll-like Receptor (TLR) Agonists & Antagonists

US$ 910.00

... description The Competitive Intelligence Report Toll-Like Receptor (TLR) Agonists & Antagonists provides a competitor analysis in the development pipeline of novel small ... with the project data to print or export an individual report. Toll-like receptors (TLRs) are a class of proteins that play a key role ...

December 2012 178 pages

India Cosmetic Surgery Market Outlook 2016

US$ 700.00

... cosmetic surgeries market inIndia. Research report “India Cosmetic Surgery Market Outlook 2016” gives comprehensive overview on the following aspects related to Cosmetic surgery segment in India. Cosmetic surgery Market Potential Treatment Cost Patient Profile & Preferred Cosmetic ...

December 2012 70 pages

U.S. Market for Fetal and Neonatal Monitoring Devices - (Part of Segment Series)

US$ 2,995.00

... Drivers & Limiters Mergers & Acquisitions Customer Feedback and Market Monitoring SubSegments Included: Fetal and neonatal monitoring Invasive and Non-Invasive ... and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The ...

November 2012 65 pages

China Wellness Industry Outlook 2016 - Potential Opportunities in Tier-2 and Tier-3 Cities in China

US$ 640.00

The report titled “China Wellness Industry Outlook 2016 - Potential Opportunities in Tier-2 and Tier-3 Cities in China” provides a comprehensive analysis of the ... observed that around 89.7% of the revenue of the health clubs market in China was generated by the domestic or local gyms or fitness centers in the ...

November 2012 70 pages

India Wellness Industry Outlook 2016 - Robust Growth in Alternative Therapy and Nutraceuticals Market

US$ 720.00

The report titled “India Wellness Industry Outlook 2016 – Robust Growth in Alternative Therapy and Nutraceuticals Market” provides a comprehensive analysis of the ... products market contributed around ~% of the fitness and slimming market in India in the year 2011. The market is expected to witness the inflow ...

November 2012 123 pages

Indian Patient Monitoring Market: Trends & Opportunities (2012-2017)

US$ 800.00

... market size and larger consumer base of patient monitors. The report titled “Indian Patient Monitoring Market: Trends and Opportunities” analyzes the growth of the patient monitoring market ...

November 2012 64 pages

Global Hearing Instruments Market Report: 2012 Edition

US$ 800.00

... hearing loss. The hearing loss is treated by hearing instruments which include two categories: Hearing Aid and Hearing Implant. The present report offers a comprehensive analysis of the worldwide hearing instrument ... Korea. The competition in the global hearing instrument market is intense with few large players ...

November 2012 53 pages

Advanced Wound Care: World Market Prospects 2013-2023

US$ 2,401.00

... grow steadily to 2023, primarily driven by an increase in the prevalence of chronic wounds including diabetic ulcers and pressure ulcers, approval of innovative devices ... key business opportunities. Why you should buy Advanced Wound Care: World Market Prospects 2013-2023 148 pages of comprehensive analysis ...

November 2012 171 pages

Medicated Skin Care in Romania

US$ 990.00

... , when they generally seek a medical recommendation, the level of self-medication increased rapidly in Bucharest and... Euromonitor International's Medicated Skin Care in Romania report offers a comprehensive guide ... Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals ...

November 2012 30 pages

Filters

Search

Categories

110,875
370
94
240
548
1,146
94

Publishers

179
1
56
100
25
102
96
2,390
188
23
40
8,299
68
562
988
34
29,954
248
501
3,036
1
1
2
3
16
257
537
361
106
1
1,357
2,180
60
1,696
8
8,921
1,898
4
3,695
983
19
1
321
4,852
2,743
66
1
3
3
36
202
2,355
246
53
50
45
46
29
29
143
56
42
83
9
20
29
5
11
3
16,308
3
274
11
3
292
22
4
39
1
2
6,125
14
1
183
49
359
30
33
4,348
13
1
44
2
7
10
9
12
18
21
168
52
8
3
18
16
7
1
18
1
41
58
593
1
4
6
1
3
9
1
3
5
1
1
1
90
2
4
4
1
81
15
1,095
1
3
1
17
227
128
16
4
397
3
74
2
6
5
10
1
3
118
33
336
198
47
474
7
45
1
25
13
138
2
4

Regions

58
48
35
31
30
29
29
26
26
23
22
22
22
21
16
15
14
6
4
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1,633
36
57
41
51
57
98
26
30
52
3
34
2
2
1,178
115
172
26
33
94
14
49
45
28
18
59
25
23
39
23
40
24
14
50
28
35
130
47
62
64
199
49
17
53
39
31
45
44
37
33
19
56
147
34
31
28
17
17
16
14
133
55
47
30
15
457
1,819
68
921
761
181
2,004
100,751

Price

Date

Pages

Offers

95
23
905
1
2,730
273
1
1